Although we observed enhanced EPHB3 expression in the colitis-associated tumors, we did not detect the EPHB3 downregulation typical of CRC progression in human samples probably because overt adenoma to carcinoma transition does not occur in this murine model of CAC, and invasive carcinoma is extremely rare. This evidence concerns the gene EPHB3 and carcinoma.